Cytokine Adsorption in Sepsis and Acute Kidney Injury

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 124 participants.

Also called NCT02588794

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 124 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02588794
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02588794. Randomized; no masking; primary purpose treatment. Start 2015-10 (registry gives no type); primary completion 2017-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cytokine Adsorption in Sepsis and Acute Kidney Injury
Acronym
CASAKI
Condition
Renal Insufficiency or Renal Failure &or End-stage Renal Disease
Intervention (Device)
CytoSorb 300 ml device (3804606CE01)
Lead sponsor
Technical University of Munich (class: other)

Record details

Record id
cardio:ct-nct02588794
Content hash
e294cfdfa23efc54370161ca933a8098a503167cf15347bd359c0a298c09dfd6